In breast cancer MDA-MB-231 cells, both type 3a AR and type 3b AR enhanced the activity of the TMPRSS enhancer reporter in the absence of androgen, and this activation was not affected by DHT treatment (Figure 4B, green and yellow columns, right graph). This evidence concerns the gene AR and breast cancer.